SCHEDULE: Daniel Farb Reduces Artelo BioSciences Stake Below 5%

Sentiment:

Beneficial Ownership Amendment 21 October 2025 5:48 PM

📋All filings for Artelo Biosciences, INC

Daniel S. Farb has reduced his beneficial ownership in Artelo BioSciences, Inc. to 0.8% after selling common stock on October 20 and 21, 2025.

Worse than expectedThe reduction of a significant beneficial owner's stake below 5% through open market sales is generally perceived negatively by investors, as it may suggest a lack of confidence in the company's future performance by an informed party.

Summary

Daniel S. Farb, a Canadian citizen, ceased to beneficially own more than 5% of Artelo BioSciences, Inc.'s outstanding shares as of October 20, 2025.
Farb's current beneficial ownership stands at 16,399 shares, representing approximately 0.8% of the total outstanding shares.
This beneficial ownership includes 11,299 shares underlying $10 Warrants that expire in June 2030.
The percentage calculation is based on a denominator of 2,008,002 shares, which includes 1,555,493 shares outstanding as of September 16, 2025, 441,210 shares issued in an October 1, 2025 offering, and the 11,299 warrant shares held by Farb.
Transactions since the last amendment include the sale of 92,800 shares at $3.9708 per share on October 20, 2025, and 55,103 shares at $3.5498 per share on October 21, 2025.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a significant beneficial owner reducing their stake below 5% through stock sales, which can be interpreted as a bearish signal for the company's stock.

Negatives

A significant beneficial owner, Daniel S. Farb, has reduced his stake below the 5% threshold, which can be interpreted as a decrease in confidence in the company's future prospects.
The sales occurred at prices of $3.9708 and $3.5498, indicating a downward trend in the sale price over two days.

Risks

The $10 Warrants held by Daniel S. Farb are subject to a Beneficial Ownership Limitation, currently set at 4.99%, preventing exercise if it would result in ownership exceeding this threshold, though it can be increased to 9.99% with 61 days' prior notice.

Future Outlook

The filing does not provide specific forward-looking statements or guidance from the company or the reporting person regarding the company's future operations or financial performance.

Industry Context

Insider selling, particularly by a significant beneficial owner reducing their stake below a key reporting threshold, is a common event in the financial markets. It can sometimes signal a lack of confidence in the company's near-term prospects, although individual liquidity needs or portfolio rebalancing can also be factors.

Stakeholder Impact

Shareholders may view the insider selling as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.
Potential investors might become more cautious due to the reduction in a significant holder's stake.

Key Dates

Date	Description
2025-09-16	Reference date for 1,555,493 shares outstanding, as disclosed in the Issuer's Corporate Presentation.
2025-09-17	Date of Issuer's Corporate Presentation, disclosing shares outstanding.
2025-10-01	Date of Issuer's underwritten offering of 441,210 shares and filing of Current Report on Form 8-K.
2025-10-20	Date Daniel S. Farb ceased to beneficially own more than 5% of outstanding shares; also date of sale of 92,800 common shares.
2025-10-21	Date of sale of 55,103 common shares; also date of filing signature.
2030-06	Expiration date of the $10 Warrants held by Daniel S. Farb.

Recommendation

hold

The insider selling by a significant beneficial owner, reducing their stake below 5%, is a negative signal. While not necessarily a 'sell' given the lack of other company-specific news, it warrants a 'hold' recommendation with increased caution and monitoring for further developments or company performance indicators. Investors should consider the implications of a knowledgeable individual reducing their exposure.

Keywords

Artelo BioSciences, ARTL, Schedule 13D/A, Beneficial Ownership, Insider Selling, Stock Sale, Warrants, Shareholder, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.